Vincent S. Madison
45Patents
12h-index
136Co-inventors
84Inventor score
Filing activity: Mar 30, 1987 → May 31, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6846802B2 | Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties | Human Necessities | 65 | Expired |
| US6914122B2 | Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties | Human Necessities | 47 | Expired |
| US6894072B2 | Compounds as NS3-serine protease inhibitors of hepatitis C virus | Chemistry; Metallurgy | 28 | Expired |
| US7119200B2 | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | Human Necessities | 26 | Expired |
| US7161003B1 | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | Human Necessities | 24 | Expired |
| US5084442A | Cyclic growth hormone releasing factor analogs and method for the manufacture thereof | Human Necessities | 20 | Expired |
| US7504424B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 18 | Expired |
| US7488745B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 17 | Active |
| US5374772A | Substituted benzoic acids, inhibitors of phospholipases A.sub.2 | Chemistry; Metallurgy | 15 | Expired |
| US7807672B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 14 | Active |
| US5324747A | N-substituted anilines, inhibitors of phospholipases A.sub.2 | Chemistry; Metallurgy | 14 | Expired |
| US4808701A | Cyclic peptides having appetite regulating activity | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7482370B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 12 | Expired |
| US5446189A | Intermediates for the production of N-substituted anilines, inhibitors of phospholipases A.sub.2 | Chemistry; Metallurgy | 10 | Expired |
| US8673924B2 | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors | Human Necessities | 10 | Active |
| US7687527B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US5298652A | N-substituted glycines, inhibitors of phospholipase A.sub.2 | Chemistry; Metallurgy | 5 | Expired |
| US8546404B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7879890B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 5 | Active |
| US7683085B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 5 | Active |
| US5013722A | Cholecystokinin analogs for controlling appetite | Human Necessities | 4 | Expired |
| US7638513B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 3 | Expired |
| US7700773B2 | 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7968683B1 | Factor IXa crystals, related complexes and methods | Physics | 2 | Active |
| US7553864B2 | Compounds for the treatment of inflammatory disorders and microbial diseases | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.